Evidence map›Paper›PMID 39458630›Full record

ArticlePharmaceutics2024

PLGA-PEG Nanoparticles Loaded with Cdc42 Inhibitor for Colorectal Cancer Targeted Therapy.

Sanazar Kadyr, Altyn Zhuraliyeva, Aislu Yermekova, Aigerim Makhambetova, Daulet B Kaldybekov, Ellina A Mun, Denis Bulanin, Sholpan N Askarova, Bauyrzhan A Umbayev

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sanazar KadyrSchool of Medicine, Nazarbayev University, 010000 Astana, Kazakhstan.ORCID 0009-0001-3958-5777
Altyn ZhuraliyevaLaboratory of Bioengineering and Regenerative Medicine, National Laboratory Astana, Nazarbayev University, 010000 Astana, Kazakhstan.
Aislu YermekovaLaboratory of Bioengineering and Regenerative Medicine, National Laboratory Astana, Nazarbayev University, 010000 Astana, Kazakhstan.
Aigerim MakhambetovaLaboratory of Bioengineering and Regenerative Medicine, National Laboratory Astana, Nazarbayev University, 010000 Astana, Kazakhstan.
Daulet B KaldybekovDepartment of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan.ORCID 0000-0002-7191-5465
Ellina A MunSchool of Sciences and Humanities, Nazarbayev University, 010000 Astana, Kazakhstan.ORCID 0000-0001-8625-9563
Denis BulaninSchool of Medicine, Nazarbayev University, 010000 Astana, Kazakhstan.
Sholpan N AskarovaLaboratory of Bioengineering and Regenerative Medicine, National Laboratory Astana, Nazarbayev University, 010000 Astana, Kazakhstan.ORCID 0000-0001-6161-1671
Bauyrzhan A UmbayevLaboratory of Bioengineering and Regenerative Medicine, National Laboratory Astana, Nazarbayev University, 010000 Astana, Kazakhstan.ORCID 0000-0002-0286-7252

Funding

Nazarbayev University Collaborative Research Project (CRP) Grant No.211123CRP1611the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP14871939
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CASINCdc42colorectal cancernanoparticlesPLGA-PEG-COOH

Identifiers

PMID39458630
PMCPMC11510643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.